Skip to main content
Log in

Evaluation of bone turnover in type I osteoporosis using biochemical markers specific for both bone formation and bone resorption

  • Original Article
  • Published:
Osteoporosis International Aims and scope Submit manuscript

Abstract

The aims of the study were to evaluate the use of bone-specific biochemical markers of turnover in type I osteoporosis, to test for evidence of heterogeneity of bone turnover in this condition, and to attempt to devise an ‘uncoupling index’ by using the relationship between bone-specific biochemical markers of bone formation and bone resorption. In women with type I osteoporosis (mean age 64 years, SD 5;n=63) the mean level of serum osteocalcin, a specific biochemical marker of bone formation, was 9.9 ng/ml (SD 2.0), which was higher than the level in normal postmenopausal women (mean age 65 years, SD 6;n=8.9 ng/ml (SD 2.0;p<0.01). The variance of serum osteocalcin levels in the two groups was similar. Compared with this 11% increase in the biochemical marker for bone formation, the markers of bone resorption, total urinary deoxypyridinoline (bone-specific), pyridinoline and hydroxyproline were increased by 40% (p<0.0001), 61% (p<0.0001) and 25% (p<0.01), respectively. Furthermore, these biochemical markers of bone resorption had greater variance in women in type I osteoporosis than in the normal postmenopausal women (p<0.001). The urinary excretion of the free crosslinks deoxypyridinoline, pyridinoline and glycosylated pyridinoline were increased by 26% (p<0.001), 17% (p<0.01) and 13% (NS) respectively. An ‘uncoupling index’ was calculated for the difference between urinary deoxypyridinoline and serum osteocalcin using the results from the normal women and expressed asz-scores. We conclude that the pyridinium crosslinks of collagen enable better discrimination between normal and osteoporotic women than does hydroxyproline. In osteoporosis there appears to be heterogeneity of bone resorption. Finally, an uncoupling index indicated that in osteoporosis bone resorption was increased to a greater extent than bone formation as compared with normal postmenopausal women.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Eastell R, Delmas PD, Hodgson SF, Erikson EF, Mann KG, Riggs BL. Bone formation rate in older normal women: concurrent assessment with bone histomorphometry, calcium kinetics, and biochemical markers. J Clin Endocrinol Metab 1988;67:741–8.

    Google Scholar 

  2. Brown JP, Delmas PD, Malaval L, Edouard C, Chapuy MC, Meunier PJ. Serum bone-gla protein: a specific marker for bone formation in postmenopausal osteoporosis. Lancet 1984;1:1091–3.

    Google Scholar 

  3. Charles P, Poser JW, Mosekilde L, Jensen FT. Estimation of bone turnover evaluated by45Ca-kinetics: efficiency of bone gamma-carboxyglutamic acid-containing protein, serum alkaline phosphatase, and urinary hydroxyproline excretion. J Clin Invest 1985;76:2254–8.

    Google Scholar 

  4. Delmas PD, Wahner HW, Mann KG, Riggs BL. Assessment of bone turnover in postmenopausal osteoporosis by measurement of serum bone Gla-protein. J Lab Clin Med 1983;102:470–6.

    Google Scholar 

  5. Duda RJ Jr, O'Brien JF, Katzmann JA, Peterson JM, Mann KG, Riggs BL. Concurrent assays of circulating bone Gla-protein and bone alkaline phosphatase: effects of sex, age, and metabolic bone disease. J Clin Endocrinol Metab 1988;66:951–7.

    Google Scholar 

  6. Deacon AC, Hulme P, Hesp R, Green JR, Tellez M, Reeve J. Estimation of whole body bone resorption rate: a comparison of urinary total hydroxyproline excretion with two radioisotopic tracer methods in osteoporosis. Clin Clim Acta 1987;166:297–306.

    Google Scholar 

  7. Klein L, Lafferty FW, Pearson OH, Curtiss PH. Correlation of urinary hydroxyproline, serum alkaline phosphatase and skeletal calcium turnover. Metabolism 1964;13:272–84.

    Google Scholar 

  8. Prockop DJ. Isotopic studies on collagen degradation and the urine excretion of hydroxyproline. J Clin Invest 1964;43:453–60.

    Google Scholar 

  9. Robins SP. An enzyme-linked immunoassay for the collagen crosslink pyridinoline. Biochem J 1982;207:617–20.

    Google Scholar 

  10. Eyre DR, Koob TJ, Van Ness KP. Quantitation of hydroxypyridinium crosslinks in collagen by high performance liquid chromatography. Anal Biochem 1984;137:380–8.

    Google Scholar 

  11. Beardsworth LJ, Eyre DR, Dickson IR. Changes with age in the urinary excretion of lysyl- and hydroxylysylpyridinoline, two new markers of bone collagen turnover. J Bone Miner Res 1990;5:671–6.

    Google Scholar 

  12. Uebelhart D, Ginevis E, Delmas PD. Urinary excretion of pyridinium crosslinks: a new marker of bone resorption in metabolic bone disease. Bone Miner 1990;8:87–96.

    Google Scholar 

  13. Fujimoto D, Suzuki M, Uchiyama A, Miyamoto S, Inoue T. Analysis of pyridinoline, a cross-linking compound of collagen fibres, in human urine. J Biochem 1983;94;1133–6.

    Google Scholar 

  14. Colwell A, Eastell R, Assiri AMA, Russell RGG. Effect of diet on deoxypyridinoline excretion. In: Christiansen C, Overgaard K, editors. Osteoporosis. Copenhagen: Osteopress ApS 1990:5901.

    Google Scholar 

  15. Robins SP, Duncan A, McLaren AM. Structural specificity of an ELISA for the collagen crosslink, pyridinoline: implications for the measur ement of free pyridinium crosslinks as indices of resorption in metabilic bone diseases. J Bone Miner Res 1991;6 (suppl 1):S244.

    Google Scholar 

  16. Robins SP, Duncan A, Riggs BL. Direct measurement of free hydroxypyridinium crosslinks of collagen in urine as new markers of bone resorption in osteoporosis. In: Christiansen C, Overgaard K editors. Osteoporosis. Copenhagen: Osteopress ApS 1990:465–8.

    Google Scholar 

  17. Riggs BL, Wahner HW, Dunn WL, Mazess RB, Offord KP, Melton LJ III. Differential changes in bone mineral density of the appendicular and axial skeleton with aging: relationship to spinal osteoporosis. J Clin Invest 1981;67:328–35.

    Google Scholar 

  18. Eastell R, Riggs BL. Diagnostic evaluation of osteoporosis. Endocrinol Metab Clin North Am 1988;17:547–72.

    Google Scholar 

  19. Black D, Duncan A, Robins SP. Quantitative analysis of the pyridinium crosslinks of collagen in urine using ion-paired reversed-phase high-performance liquid chromatography. Anal Biochem 1988;169:197–203.

    Google Scholar 

  20. Eastell R, Simmons PS, Colwell A, Assiri AMA, Burritt MF, Russell RGG, Riggs BL. Nyctohemeral changes in bone turnover assessed by serum bone Gla-protein concentration and urinary deoxypyridinoline excretion: effects of growth and ageing. Clin Sci 1992;83:375–82.

    Google Scholar 

  21. Delmas PD, Stenner D, Wahner HW, Mann KG, Riggs BL. Increase in serum bone gamma-carboxyglutamic acid protein with aging in women. J Clin Invest 1983;71:1316–21.

    Google Scholar 

  22. Dawson C, Jewel S, Driskell W. Liquid chromatographic determination of total hydroxyproline in urine. Clin Chem 1988;34:1572–4.

    Google Scholar 

  23. Eriksen EF, Hodgson SF, Eastell R, Cedel SL, O'Fallon WM, Riggs BL. Cancellous bone remodelling in type I (postmenopausal) osteoporosis: quantitative assessment of rates of formation, resorption, and bone loss at tissue and cellular levels. J Bone Miner Res 1990;5:311–20.

    Google Scholar 

  24. Podenphant J, Johansen JS, Thomsen K, Riis BJ, Leth A, Christiansen C. Bone turnover in spinal osteoporosis. J Bone Miner Res 1987;2:497–503.

    Google Scholar 

  25. Parfitt AM, Mathews C, Rao D, Frame B, Kleerekoper M, Vallanuera AR. Impaired osteoblast function in metabolic bone disease. In: DeLuca HF, Frost HM, Jee WS, Johnston CG Jr, Parfitt AM, editors. Osteoporosis: recent advances in pathogenesis and treatment. Baltimore: University Park Press, 1981:321–30.

    Google Scholar 

  26. Lauffenburger T, Olah AJ, Dambacher MA, Guncaga J, Lentner C, Itaas HG. Bone remodelling and calcium metabolism: a correlated histomorphometric, calcium kinetic, and biochemical study in patients with osteoporosis and Paget's disease. Metabolism 1977;26:589–606.

    Google Scholar 

  27. Moskowitz RW, Klein L, Katz D. Urinary hydroxyproline levels in an aged population: a study of non-osteoporotic and osteoporotic patients. Arthritis Rheum 1965;8:61–8.

    Google Scholar 

  28. Meunier PJ, Sellami S, Briancon D, Edouard C. Histological heterogeneity of apparently idiopathic osteoporosis. In: DeLuca HF, Frost HM, Jee WSS, Johnson CC Jr, Parfitt AM, editors. Osteoporosis: recent advances in pathogenesis and treatment. Baltimore: University Park Press, 1981:293–301.

    Google Scholar 

  29. Nordin BEC, Aaron J, Speed R, Crilly RG. Bone formation and resorption as the determinants of trabecular bone volume in postmenopausal osteoporosis. Lancet 1981;2:277–9.

    Google Scholar 

  30. Whyte MP, Bergfeld MA, Murphy WA, Avioli LV, Teitelbaum SL. Postmenopausal osteoporosis: a heterogeneous disorder as assessed by histomorphometric analysis of iliac crest bone from untreated patients. Am J Med 1982;72:193–202.

    Google Scholar 

  31. Delmas PD, Schlemmer A, Gineyts E, Riis B, Christiansen C. Urinary excretion of pyridinoline crosslinks correlates with bone turnover measured on iliac crest biopsy in patients with vertebral osteoporosis. J Bone Miner Res 1991;6:639–44.

    Google Scholar 

  32. Eastell R, Hampton L, Colwell A, Green JR, Assiri AMA, Hesp R, Russell RGG, Reeve J. Urinary collagen crosslinks are highly correlated with radioisotopic measurements of bone resorption. In: Christiansen C, Overgaard K, editors. Osteoporosis. Copenhagen: Osteopress ApS 1990:469–70.

    Google Scholar 

  33. Eastell R, Riggs BL. Treatment of osteoporosis. Obstet Gynecol Clin North Am 1987;14:77–88.

    Google Scholar 

  34. Christiansen C, Riis BJ, Rodbro P. Prediction of rapid bone loss in postmenopausal women. Lancet 1987;1:1105–8.

    Google Scholar 

  35. Uebelhart D, Schlemmer A, Johansen JS, Gineyts E, Christiansen C, Delmas PD. Effect of menopause and hormone replacement therapy on the urinary excretion of pyridinium crosslinks. J Clin Endocrinol Metab 1991;72:367–73.

    Google Scholar 

  36. Stepan JJ, Pospichal J, Presl J, Pacovsky V. Bone loss and biochemical indices of bone remodelling in surgically induced postmenopausal women. Bone 1987;8:279–84.

    Google Scholar 

  37. Blumsohn A, Eastell R. Commentary: prediction of bone loss in postmenopausal women. Eur J Clin Invest 1992;22:764–6.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Eastell, R., Robins, S.P., Colwell, T. et al. Evaluation of bone turnover in type I osteoporosis using biochemical markers specific for both bone formation and bone resorption. Osteoporosis Int 3, 255–260 (1993). https://doi.org/10.1007/BF01623829

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01623829

Keywords

Navigation